SLN
Silence TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SLN vs peer average
34/100
SLN vs. peer average (F vs. D)
Grade spread
A 1 · D 7 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
FHTX is the first available peer comparator.
Less direct scientifically, but still a small-cap development-stage biotech with platform optionality and sentiment that swings with milestone cadence rather than current commercial revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SLN
Silence Therapeutics
FHTX
Foghorn Therapeutics
Grade
F
D
Momentum
100
2
Value
41
59
Sentiment
0
42
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs FHTX
SLN / FHTX
Grade Position
Below peers
SLN vs. peer average (F vs. D)
34/100
Momentum
100
SLNValue
41
FHTXSentiment
0
FHTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SLN
FHTX is the first peer returned for this comparison set.